Entero Therapeutics logo

Entero Therapeutics share price today

(ENTO)

Entero Therapeutics share price is $0.59 & ₹50.05 as on 12 Dec 2024, 2.30 'hrs' IST

$0.59

-0.06

(-9.82%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Entero Therapeutics share price in Dollar and Rupees. Guide to invest in Entero Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Entero Therapeutics. Get details on the Indian mutual funds that are investing in Entero Therapeutics. Get Analyst recommendations and forecasts along with all the Entero Therapeutics's financials.

Entero Therapeutics share price movements

  • $0.55
    $0.66

    Day's Volatility :16.58%

  • $0.19
    $3.16

    52 Weeks Volatility :94.15%

Entero Therapeutics Returns

PeriodEntero Therapeutics IncIndex (Russel 2000)
3 Months
97.58%
0.0%
6 Months
-70.36%
0.0%
1 Year
-78.12%
0.0%
3 Years
-78.12%
-20.0%

Entero Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.652
Open
$0.6066
Today's High
$0.659999
Today's Low
$0.5506
Market Capitalization
$1.1M
Today's Volume
$591.2K
52 Week High
$3.16
52 Week Low
$0.185
Revenue TTM
$0.0
EBITDA
$-20.9M
Earnings Per Share (EPS)
$-11.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-15.28%

How to invest in Entero Therapeutics from India?

It is very easy for Indian residents to invest directly in Entero Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Entero Therapeutics stock in both rupees (INR) and dollars (USD). Search for Entero Therapeutics or ENTO on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Entero Therapeutics or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Entero Therapeutics shares which would translate to 1.438 fractional shares of Entero Therapeutics as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Entero Therapeutics

-24%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Entero Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 12, 2024. -24% less investors are searching Entero Therapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Entero Therapeutics

Analyst Forecast on Entero Therapeutics

What analysts predicted

Upside of 6001.69%

Current:

$0.59

Target:

$36.00

Insights on Entero Therapeutics

  • Price Movement

    In the last 7 days, ENTO stock has moved up by 31.5%

Entero Therapeutics Technicals Summary

Sell

Neutral

Buy

Entero Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Entero Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Entero Therapeutics Inc
5.16%
-70.36%
-78.12%
-78.12%
-78.12%
Regeneron Pharmaceuticals, Inc.
-5.71%
-24.16%
-11.14%
17.93%
107.04%
Biontech Se
7.47%
21.72%
20.24%
-58.0%
233.86%
Alnylam Pharmaceuticals, Inc.
-9.26%
58.64%
40.65%
36.2%
111.38%
Vertex Pharmaceuticals Incorporated
-6.48%
-2.05%
15.84%
125.42%
113.77%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Entero Therapeutics Inc
NA
NA
NA
-1.13
-0.15
-0.27
NA
7.99
Regeneron Pharmaceuticals, Inc.
19.27
19.27
1.17
45.03
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.24
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Entero Therapeutics Inc
NA
$1.1M
-78.12%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$86.6B
107.04%
19.27
33.61%
Biontech Se
Buy
$28.0B
233.86%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$33.0B
111.38%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$122.1B
113.77%
32.84
-4.51%

About Entero Therapeutics

azurrx biopharma aims to become a leader in developing non-systemic, recombinant protein therapies for the treatment of gastrointestinal diseases and related conditions. ms1819 recombinant lipase for exocrine pancreatic insufficiency is the lead development program with additional early stage research being conducted for the prevention of hospital-acquired infection. the company is headquartered in new york, ny, with scientific operations based in langlade, france.
Organization
Entero Therapeutics
Employees
9
CEO
Mr. James R. Sapirstein M.B.A., R.Ph.
Industry
Miscellaneous

Management People of Entero Therapeutics

NameTitle
Mr. James R. Sapirstein M.B.A., R.Ph.
CEO & Chairman
Ms. Sarah Romano CPA
Chief Financial Officer
Ms. Amy Chandler-Skerkis
Vice President of Regulatory Affairs, QA & Compliance
Mr. Martin Krusin M.B.A.
Senior Vice President of Corporate Development
Ms. Jennifer A. Sealey-Voyksner Ph.D.
Senior VP for Research & Development

Important FAQs about investing in Entero Therapeutics from India :

What is Entero Therapeutics share price today?

Entero Therapeutics (ENTO) share price today is $0.59.

Can Indians buy Entero Therapeutics shares?

Yes, Indians can invest in the Entero Therapeutics (ENTO) from India.

With INDmoney, you can buy Entero Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Entero Therapeutics at zero transaction cost.

How can I buy Entero Therapeutics shares from India?

It is very easy to buy Entero Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Entero Therapeutics be purchased?

Yes, you can buy fractional shares of Entero Therapeutics with INDmoney app.

What are the documents required to start investing in Entero Therapeutics stocks?

To start investing in Entero Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Entero Therapeutics

Today’s highest price of Entero Therapeutics (ENTO) is $0.66.

Today’s lowest price of Entero Therapeutics (ENTO) is $0.55.

What is today's market capitalisation of Entero Therapeutics

Today's market capitalisation of Entero Therapeutics ENTO is 1.1M

What is the 52 Week High and Low Range of Entero Therapeutics

  • 52 Week High

    $3.16

  • 52 Week Low

    $0.19

How much percentage Entero Therapeutics is down from its 52 Week High?

Entero Therapeutics (ENTO) share price is $0.59. It is down by 81.33% from its 52 Week High price of $3.16.

How much percentage Entero Therapeutics is up from its 52 Week low?

Entero Therapeutics (ENTO) share price is $0.59. It is up by 218.92% from its 52 Week Low price of $0.19.

What are the historical returns of Entero Therapeutics?

  • 1 Month Returns

    5.16%

  • 3 Months Returns

    -70.36%

  • 1 Year Returns

    -78.12%

  • 5 Years Returns

    -78.12%

Who is the Chief Executive Officer (CEO) of Entero Therapeutics

Mr. James R. Sapirstein M.B.A., R.Ph. is the current Chief Executive Officer (CEO) of Entero Therapeutics.